Efficacy of Formal Screening for Depression in Pediatric Type 1 Diabetes Clinic
This study was undertaken to examine the efficacy of screening for depression in a
pediatric diabetes clinic and how the yield of such screening compares with established
screening protocols aimed at identifying early microvascular complications and
associated autoimmune diseases. Two-hundred-fifteen children and adolescents 8-18
years old in the Yale Pediatric Diabetes Center were screened for depression using the
Children¡¯s Depression Inventory (CDI), with information including gender, age, duration
of diabetes, HbA1C, and results of other screening protocols compiled.
A total of 8.4% of our cohort had CDI scores ¡Ý13 indicative of clinically-significant
depressive symptoms, with a range of 0-34. Depression scores were not associated with
gender, age, or HbA1C. However, duration of diabetes showed a trend toward statistical
significance (adjusted p=.068). Screening for depression using the CDI with a cutoff of
¡Ý13 had similar positive testing rates as screening for microalbuminuria,
hypercholesterolemia, thyroid dysfunction, and celiac sprue; in contrast, none of the
clinic patients had evidence of retinopathy at their last ophthalmologic examination.
These findings indicate that screening for depression in a pediatric diabetes clinic
identifies a substantial number of youngsters with high levels of depressive symptoms
and has a yield that is equal to or greater than other standard screening tests and
examinations. Thus, screening appears to be warranted.
School Location:USA - Connecticut
Source Type:Master's Thesis
Keywords:yale pediatric diabetes center new haven connecticut questionnaires depression humans adolescent child mellitus type 1 female diagnosis male
Date of Publication:04/12/2009